Covid-19 News

  • „With absolute no relevance for the vaccine“ - will take your judgement with a grain of salt, unless there is other evidence out there from other sources, that state the same. Pfizer is anyway one of your big enemies, so there is kind of bias from your end with everything they claim, publish or state. Again: let’s wait and see.

  • No Gilead is even worse selling crap that lets people die 3x longer...


    Here once more the true paper (not the fake version in business report..) https://www.biorxiv.org/conten…1.01.22.427749v1.full.pdf

    There is one more...But as you wont read it anyway a spare my time.

    Let's take that paper one more step. Early treatment is the only way out of this


    Circulating SARS-CoV-2 variants B.1.1.7, 501Y.V2, and P.1 have gained ability to utilize rat and mouse Ace2 and altered in vitro sensitivity to neutralizing antibodies and ACE2-Ig


    https://www.biorxiv.org/conten…/2021.01.27.428353v2.full


    Results

    Spike RBD is the major determinant of viral receptor usage and neutralization sensitivity, we thus primarily focused on RBD mutations found in different variants, especially the Variants of Concern (VOC) that emerged from the UK (VOC202012/01, also known as B.1.1.7 or 501Y.V1), South Africa (VOC202012/02, also known as 501Y.V2 or B.1.351), and Brazil (VOC202101/02, also known as P.1 or 501Y.V3), respectively. These include an N439K mutation from the circulating variant B.1.141ref.20, an N501Y mutation from B.1.1.7/501Y.V1 21,22, E484K and N501Y mutations from B.1.351/501Y.V223 and P.1/501Y.V3 24, and a Y453F mutation from two mink-associated variants that emerged in Netherlands and Denmark mink farms25–27 (Figure 1). We further included a Spike Y453F-Q498H double mutant that has not been detected in patient samples yet, but could evolve from the early isolate WHU01 through adopting only two nucleotide mutations, or from the mink-associated Y453F variant through adopting a single nucleotide mutation. To evaluate Spike protein-mediated viral entry of the above-mentioned variants, we constructed Spike expression plasmids for these variants and produced luciferase reporter retroviruses pseudotyped with one of these different Spike variants. As rats and mice are rodent species that have huge population size and could have close contacts with human and domestic animal populations, it’s important to monitor SARS-CoV-2’s ability to utilize rat and mouse Ace2 as receptor. We therefore used the Spike variant-pseudotyped reporter viruses to infect 293T cells transfected with an expression plasmid of human, rat, or mouse ACE2 ortholog. Parallel infection experiments using 293T cells transfected with an empty vector plasmid were included as controls. Consistent with our previous report, the early strain WHU01 only infected 293T cells expressing human ACE2, but not rat or mouse Ace2 (Figure 2A). Though the variant carrying Δ(69-70)-N439K mutations and the mink-associated variant carrying Δ(69-70)-Y453F mutations did so too (Figures 2B and C), the mink-associated variant that carries Δ(69-70)-Y453F-F486L-N501T-M1229I mutations also infected 293T cells expressing mouse Ace2, albeit with much lower efficiency than infecting cells expressing human ACE2 (Figure 2D). It is of note that, in addition to the Y453F-Q498H variant, all the variants that carry an N501Y mutation efficiently utilized all the three Ace2 orthologs (Figures 2E-H). The variant that carries K417N-E484K-N501Y mutations utilized rat Ace2 even more efficiently than using human ACE2 (Figure 2G). These data suggest that the circulating SARS-CoV-2 variants B.1.1.7/501Y.V1, B.1.351/501Y.V2, and P.1/501Y.V3 may be able to efficiently infect mice and rats, adding one more concerning factor to these VOC strains.

  • What's not so good is she repeatedly blames herself getting Covid on not wearing a mask! This is an indication that she listens exclusively to main stream media.

    It is an indication she listens to real doctors and public health officials instead of crackpots who claim that masks don't work. The data proves masks greatly reduce the likelihood of getting the disease.

  • It is an indication she listens to real doctors and public health officials instead of crackpots who claim that masks don't work. The data proves masks greatly reduce the likelihood of getting the disease.

    That statement will be put to the test in a few weeks, I hope you and the experts are right, I will be masked up but I'm no longer convinced any measures will stop the spread including lockdowns.

    The next wave will peak around the 3rd week of March and early treatment is the only way out of a huge death toll.

  • That statement will be put to the test in a few weeks,

    [The statement that masks work.] It has already been put to the test. Look at the data from Taiwan and Japan. They have not even started vaccinations in Japan but the numbers are way down, thanks entirely to masks and social distancing.


    https://www.worldometers.info/coronavirus/country/japan/


    You can also compare cities in the U.S., both now and in 1918. Masks make a huge difference.


    The next wave will peak around the 3rd week of March and early treatment is the only way out of a huge death toll.

    Only in places where people are too stupid to wear mask. There will be no next wave in Taiwan or Japan. Early treatment is not needed if you never get the disease in the first place. If everyone wears a mask, practically no one gets it. Of course it will continue at a low rate indefinitely without a vaccine, but the vaccines will eliminate it. One of them is being tweaked now so that it will be effective against the S. Africa strain. Fortunately, these mRNA vaccines can be tweaked quickly.

  • No Gilead is even worse selling crap that lets people die 3x longer...


    Here once more the true paper (not the fake version in business report..) https://www.biorxiv.org/conten…1.01.22.427749v1.full.pdf

    There is one more...But as you wont read it anyway a spare my time.

    In the summary you can read:


    "Taken together the results suggest that N501Y.V1 and N501Y.V238 reduce neutralization sensitivity to some convalescent sera and mAbs." That is in your conclusion: "with absolute no relevance to the vaccine", isn't it?" Just asking...

  • Oxford Covid vaccine has 10% efficacy against South African variant, study suggests


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen


    The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have suggested.


    Scientists who conducted a small-scale trial of the vaccine’s efficacy said it showed very little protection against mild to moderate infection, though they expressed hope that – in theory – it would still offer significant protection against more serious infection.

    The disappointing results came as lab tests on the Pfizer/BioNtech vaccine found it may still provide substantial protection against the variant. Scientists at the University of Texas medical branch collected antibody-containing blood plasma from 20 people who recently had two shots of the Pfizer/BioNTech jab.

    In tests, the antibodies were on average 81% as effective at neutralising the engineered virus as they were at blocking older variants. The results, reported in Nature Medicine, suggest the variant’s key mutation, known as E484K, does not dramatically undermine the vaccine’s protection.


    South Africa has halted the rollout of the Oxford/AstraZeneca jab, while a UK health minister indicated that an annual Covid jab could become the norm for many people as scientists work to stay a step ahead of the virus’s mutations.


    Prof Shabir Madhi from the University of the Witwatersrand, who led the trial, said that, while the study was small, it was designed to focus on determining whether or not the vaccine had at least 60% efficacy against Covid to any degree of severity.

  • Oxford Covid vaccine has 10% efficacy against South African variant, study suggests

    I do not know about the Oxford one, but the others apparently work. Also, they can be reprogrammed rapidly. I think I read that one is already being tweaked.


    See (free access to this):


    https://www.washingtonpost.com…7-49a6d1f9dff1_story.html


    Vaccines will work against new coronavirus variants spreading through U.K. and South Africa, experts believe


    Coronavirus mutations identified in the United Kingdom and South Africa may be provoking alarm, but infectious-disease experts are optimistic the new variants are still vulnerable to the powerful hammer of newly authorized vaccines. Even if the virus were to mutate further, the experts say, the vaccines could be rapidly reprogrammed to remain effective against new variants.


    Such a tweaking of the vaccines could be done “in minutes,” said Drew Weissman, a professor of medicine at the University of Pennsylvania’s Perelman School of Medicine and one of the inventors of the messenger RNA technology that powers both vaccines.


    “It’s very easy,” Weissman added.

  • The onion couldn't make something this hilarious. They want us to be updatable and in an operating system of sorts. We know it, you know it, you know we know it, we know you know we know it. The "you" being the deep state pushing this stuff.


    On the 8th day God created vaccines. On the 9th day God created computers. On the 10th day God created programmable vaccines and nanotech responsive to high frequency EMFs controllable by computers. On the 11th day God made humans merge with God. We are half way through the 10th day.

  • Probably a new secret nano-microchip from Gates is already been flowing in the blood of many people so they can be controlled if deep state wants to do so (e.g. make those population think they know everything about investing on stock exchanges .... Maybe the recent rally of some garbage stocks has been initiated somehow that way? Sorry, couldn't resist :D

  • DR Campbell opinion on South Africa suspension of Oxford

    AZ vaccine.Starting at 10:55.


    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.


    South African Goverment advisor

    interview.

    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • That is in your conclusion:

    What is your real problem??


    There is nothing in the paper you listed that is of relevance. Pfizer many times so far did select a few blood samples that did confirm that their vaccine works. This is not science just simply fraud. As the antibody concentration varies by a factor of 10, after the Pfizer vaccination, you can always find some working one...

    Compare it to the other paper... But that's obviously not what you want...


    According your childish post history - see above - we certainly will miss your first real contribution to the discussion.

    The variant that carries K417N-E484K-N501Y mutations utilized rat Ace2 even more efficiently than using human ACE2 (Figure 2G).

    They didn't want to stop CoV-19 with ivermectin. If it jumps to mice & rats then also vaccination will be no more help as an animal population will speed up the turnaround for new mutations.


    It's no problem for me as I anyway will not take a vaccine, that is not tested for at least 5 years. Certainly not for a flu like illness that can be easily cured. May be I have to buy more ivermectin...

  • Japanese doctors warn of long-lasting COVID-19 aftereffects among young people


    https://www.japantimes.co.jp/n…ftereffects-long-lasting/


    Doctors are warning that many people who contract the coronavirus, especially younger patients, are suffering aftereffects for a lengthy period of time despite subsequently testing negative for the virus.


    “Most of them are in their 40s or younger. The government needs to take the issue seriously and implement countermeasures,” one of the doctors said.

    The aftereffects include malaise and difficulty breathing. In severe cases, patients became bedridden even though they had been diagnosed with a mild case of COVID-19 caused by the virus.


    So far in Japan, there are not many medical institutions that treat patients suffering from such long-lasting effects.


    Kaai Akimoto, a 30-year-old president of a nursing care company, was diagnosed with the virus in November and her sense of taste had not returned as of January. “I wonder how long it will last,” she said.


    She sought the advice of an otolaryngologist who told her that nothing could be done. Another doctor prescribed her traditional kampō herbal medicine, but her condition did not improve.


    Recently, she has a hard time eating because hot food smells strange to her.


    Akimoto has been sharing her experience on Twitter. “There is little information, and many people are scared. I hope I can help people deepen their understanding.”


    Studies on the long-lasting effects of coronavirus infections are underway in some countries such as Italy and the United States.


    In Japan, the National Center for Global Health and Medicine conducted a telephone survey last year on coronavirus patients who had been discharged from hospitals. They collected answers from 63 individuals.


    The survey found that in some cases, people continued to experience difficulty breathing, malaise, and olfactory disorders (reduced ability to smell) four months after they started showing COVID-19 symptoms.


    There were also cases where patients experienced hair loss several months after contracting the disease, the center said.


    No treatment has been established for long-lasting COVID-19 effects, said Hiroshi Odaguchi, director general of the Kitasato University Oriental Medicine Research Center. “I believe doctors are struggling to respond.”

  • Ischgl 2.0 or how stupid one can be?


    According to a news report of today, it seems clear that Tyrol, Austria has more confirmed RSA strain cases (approx. 300) than the UK with approx. 100.

    Why is that?

    A few wealthy tourism managers chartered a private airplane for a golf trip to South Africa around Christmas. (ignoring lockdown!)

    Guess what happened. Yes, they obviously imported B.1.351!

  • Doctors are warning that many people who contract the coronavirus, especially younger patients, are suffering aftereffects for a lengthy period of time despite subsequently testing negative for the virus.

    There are "long haul" patients everywhere. The estimates of how many there are vary a lot. They need to start vaccinating in Japan. I do not understand why it is taking so long. Vaccinations for healthcare workers will begin in 2 weeks, but vaccinations for the general population over age 65 will not begin until the middle of March.


    https://www.japantimes.co.jp/n…pan-vaccination-schedule/

  • Covid reinfections may be more common than realized. Why isn't the U.S. tracking them?


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen


    As millions of Americans struggle to recover from Covid-19 and millions more scramble for the protection offered by vaccines, U.S. health officials may be overlooking an unsettling subgroup of survivors: those who get infected more than once. Identifying how common reinfection is among people who contracted Covid-19 — as well as how quickly they become vulnerable and why — carries important implications for our understanding of immunity and the nation’s efforts to devise an effective vaccination program.

    Scientists have confirmed that reinfections after initial illness caused by the SARS-CoV-2 virus are possible, but so far have characterized them as rare. Fewer than 50 cases have been substantiated worldwide, according to a global reinfection tracker. Just five have been substantiated in the U.S., including two detected in California in late January.


    That sounds like a rather insignificant number. But scientists’ understanding of reinfection has been constrained by the limited number of U.S. labs that retain Covid-19 testing samples or perform genetic sequencing. A KHN review of surveillance efforts finds that many U.S. states aren’t rigorously tracking or investigating suspected cases of reinfection.


    Another indictment of our 37th ranked healthcare system in the world!

  • A Few Covid Vaccine Recipients Developed a Rare Blood Disorder


    https://news.google.com/articl…=en-US&gl=US&ceid=US%3Aen


    One day after receiving her first dose of Moderna’s Covid vaccine, Luz Legaspi, 72, woke up with bruises on her arms and legs, and blisters that bled inside her mouth.


    She was hospitalized in New York City that day, Jan. 19, with a severe case of immune thrombocytopenia — a lack of platelets, a blood component essential for clotting.


    The same condition led to the death in January of Dr. Gregory Michael, 56, an obstetrician in Miami Beach whose symptoms appeared three days after he received the Pfizer-BioNTech vaccine. Treatments failed to restore his platelets, and after two weeks in the hospital he died from a brain hemorrhage.


    It is not known whether this blood disorder is related to the Covid vaccines. More than 31 million people in the United States have received at least one dose, and 36 similar cases had been reported to the government’s Vaccine Adverse Event Reporting System, VAERS, by the end of January. The cases involved either the Pfizer-BioNTech or Moderna vaccine, the only two authorized so far for emergency use in the United States.

    Hematologists with expertise in treating immune thrombocytopenia said they suspected that the vaccine did play a role. But they said that cases after vaccination were likely to be exceedingly rare, possibly the result of an unknown predisposition in some people to react to the vaccine by developing an immune response that destroys their platelets. The disorder has occurred, rarely, in people who received other inoculations, particularly the measles-mumps-rubella one.


    “I think it is possible that there is an association,” Dr. James Bussel, a hematologist and professor emeritus at Weill Cornell Medicine who has written more than 300 scientific articles on the platelet disorder, said in an interview. “I’m assuming there’s something that made the people who developed thrombocytopenia susceptible, given what a tiny percentage of recipients they are.”


    He added: “Having it happen after a vaccine is well-known and has been seen with many other vaccines. Why it happens, we don’t know.”


    Dr. Bussel said it was important to share information about the cases, because severe thrombocytopenia can be serious, and physicians need to know how to treat it. Sometimes the condition resists standard therapies, and if very low platelet counts persist, the patient faces an increasing risk of severe bleeding and even brain hemorrhage.


    He and a colleague, Dr. Eun-Ju Lee, have submitted an article to a medical journal on 15 cases in Covid vaccine recipients they identified by searching the government’s database or by consulting with other physicians treating patients. The report provides information about treatments and urges doctors to report cases. It also notes that it is too soon to tell whether the affected patients will have lasting recoveries, or recurrences of the platelet problem

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.